NRSA Training Core

NRSA 培训核心

基本信息

  • 批准号:
    9261157
  • 负责人:
  • 金额:
    $ 129.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-18 至 2021-05-31
  • 项目状态:
    已结题

项目摘要

Contact PD/PI: Grandis, Jennifer Rubin NRSA-Training-001 (564) TL1 Abstract The fundamental goal of the UCSF Clinical and Translational Science Institute TL1 Training Program is to provide pre-doctoral and post-doctoral fellows with the methodological, analytic, leadership, and team science skills required to conduct transformative clinical and translational research relevant to precision health. To date, the Program has served only pre-doctoral fellows, who have co-authored 846 papers (2006-2014); 89% of trainees > 5 years following the TL1 experience report that they occupy academic positions; 89% report that the TL1 experience was worthwhile and influenced their commitment to a research career. The Program now proposes to expand to admit both pre-doctoral and post-doctoral clinical and PhD fellows, recruited from all 4 professional schools at UCSF (Medicine, Dentistry, Pharmacy and Nursing), with the following Aims: Aim 1. To enhance the highly successful TL1 program to train outstanding pre-doctoral professional students by creating a new 1-year training track that will allow them to obtain a Master's in Clinical Research; Aim 2. To stimulate UCSF pre-doctoral professional students to pursue careers as clinical and translational precision health researchers through short duration mentored research experiences; and Aim 3. To expand the Program to include 5 clinical and 5 PhD post-doctoral fellows per year, with the aim of enhancing their skills to ensure success as clinical and translational precision health researchers. All trainees will be supported by committees of their lead mentor and relevant co-mentors to help them devise and execute their individual development plans (IDP). All fellows will take didactic coursework supplemented by precision health-oriented coursework tailored to the IDP, carry out an individual precision health mentored research project, participate in bi-weekly faculty presentations and student-led works-in-progress, and have the option of pursuing internships or externships. This proposal aims to expand the successful pre-doctoral program, which confers an MD and Master's in Clinical Research in 5 years, to 8 year-long fellows. Four of these will be admitted to the TL1 Program concurrently with their medical school admissions process; an additional 4 fellows will be admitted after the first year of medical school. They will participate in TL1 activities after year 3 of medical school, and complete the required Advanced Training in Clinical Research (ATCR) Certificate Program and a Master's in Clinical Research by the end of the fifth year. Short-term pre-doctoral slots (3-4 months) will be offered to 10 professional students between years 1 and 2 of education, providing them with an intense introduction to clinical and translational precision health research. For the first time, the TL1 will provide precision health research training for 5 clinical and 5 PhD post-doctoral fellows with an emphasis on team science. Post- doctoral fellows will be required to complete the ATCR with the option to obtain the Master's. The TL1 will leverage UCSF's unique strengths and partnerships with basic scientists, biopharmaceutical investigators, and industry to position the fellows to advance Clinical and Translational Science related to precision health. Project Summary/Abstract Page 1496 Contact PD/PI: Grandis, Jennifer Rubin NRSA-Training-001 (564) References for J: TL1 1. Jameson JL and Longo DL. Precision Medicine—personalized,problematic, and promising. NEJM. 2015 Jun 4; 372(23):2229-34. PMID:26014593 2. Hawgood S, Hook-Barnard IG, O'Brien TC, Yamamoto KR. Precision medicine: Beyond the inflection point. Sci Transl Med. 2015 Aug 12; 7(300):300ps17. PMID:26268311 3. Nathan DG. Clinical research: perceptions, reality, and proposed solutions. National Institutes of Health Director's Panel on Clinical Research. JAMA. 1998 Oct 28;280(16):1427-31. PMID: 9801003 4. Nathan DG, Varmus HE. The National Institutes of Health and clinical research: a progress report. Nat Med 2000 Nov;6:1201-4. PMID:11062519 References Cited Page 1497
联系PD/PI:Grandis,Jennifer Rubin NRSA-Training-001(564) TL 1摘要 UCSF临床和转化科学研究所TL 1培训计划的基本目标是 为博士前和博士后研究员提供方法论,分析,领导力和团队科学 开展与精准健康相关的变革性临床和转化研究所需的技能。到 迄今为止,该计划只为博士前研究员提供服务,他们共同撰写了846篇论文(2006-2014); 89% 在TL 1经历后> 5年的受训者报告说,他们担任学术职务; 89%的人报告说, TL 1的经历是值得的,并影响了他们对研究事业的承诺。该计划现在 建议扩大到招收博士前和博士后临床和博士研究员,从所有4个 UCSF的专业学校(医学,牙科,药学和护理),具有以下目标:目标1。到 加强非常成功的TL 1计划,通过创建培养优秀的博士前专业学生 一个新的为期1年的培训轨道,将使他们获得硕士学位的临床研究;目标2。刺激 UCSF博士前专业学生追求的职业生涯作为临床和翻译的精确健康 研究人员通过短期指导的研究经验;和目标3。为了扩大该计划, 包括每年5名临床和5名博士博士后研究员,目的是提高他们的技能,以确保 作为临床和转化精准健康研究人员的成功。所有学员将得到委员会的支持 他们的主要导师和相关的共同导师,以帮助他们设计和执行他们的个人发展 计划(IDP)。所有研究员都将参加教学课程,并辅以精确的健康导向课程 为IDP量身定制,开展个人精准健康指导研究项目,参加双周一次的 教师演示文稿和学生主导的工作在进行中,并有追求实习或 实习生该提案旨在扩大成功的博士预科课程,该课程授予MD和 5年内获得临床研究硕士学位,8年内获得研究员学位。其中四个将被接纳为TL 1 计划同时与他们的医学院录取过程;另外4名研究员将被录取 在医学院的第一年之后。他们将在医学院3年级后参加TL 1活动, 完成所需的临床研究高级培训(ATCR)证书课程和硕士学位, 临床研究到第五年年底。短期博士前插槽(3-4个月)将提供给10 专业学生之间的第1年和第2年的教育,为他们提供了一个激烈的介绍, 临床和转化精准健康研究。TL 1将首次提供精准健康 为5名临床和5名博士博士后研究员提供研究培训,重点是团队科学。后 博士研究员将被要求完成ATCR与选择获得硕士学位。TL 1将 利用UCSF的独特优势和与基础科学家,生物制药研究人员的伙伴关系, 行业定位研究员推进与精准健康相关的临床和转化科学。 项目摘要/摘要第1496页 联系PD/PI:Grandis,Jennifer Rubin NRSA-Training-001(564) J:TL 1的参考文献 1. Jameson JL和Longo DL.精准医疗-个性化,有问题,有前途。NEJM. 2015年6月4日; 372(23):2229-34。PMID:26014593 2. Hawgood S,Hook-Barnard IG,奥布莱恩TC,山本KR.精准医疗:超越拐点 点Sci Transl Med. 2015年8月12日; 7(300):300 ps17。PMID:26268311 3.内森·DG临床研究:感知、现实和建议的解决方案。国立卫生研究院 临床研究主任小组。JAMA. 1998年10月28日;280(16):1427-31。PMID:9801003 4. Nathan DG,Varmus HE。美国国立卫生研究院和临床研究:进展报告。Nat 医学2000年11月;6:1201-4。PMID:11062519 第1497页引用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAMRAN ATABAI其他文献

KAMRAN ATABAI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAMRAN ATABAI', 18)}}的其他基金

Integrin regulation of insulin sensitivity
整合素调节胰岛素敏感性
  • 批准号:
    10646291
  • 财政年份:
    2022
  • 资助金额:
    $ 129.45万
  • 项目类别:
Investigating the role of cell-mediated collagen turnover in regulating tissue fibrosis
研究细胞介导的胶原蛋白周转在调节组织纤维化中的作用
  • 批准号:
    10067379
  • 财政年份:
    2017
  • 资助金额:
    $ 129.45万
  • 项目类别:
integrin-mediated regulation of enterocyte lipid homeostasis
整合素介导的肠上皮细胞脂质稳态调节
  • 批准号:
    9156469
  • 财政年份:
    2016
  • 资助金额:
    $ 129.45万
  • 项目类别:
The Role of Collagen Uptake in Regulating the Severity of Pulmonary Fibrosis
胶原蛋白摄取在调节肺纤维化严重程度中的作用
  • 批准号:
    8598509
  • 财政年份:
    2011
  • 资助金额:
    $ 129.45万
  • 项目类别:
Identification of Pathways that Regulate Fibrosis through Collagen Resorption
鉴定通过胶原吸收调节纤维化的途径
  • 批准号:
    8250331
  • 财政年份:
    2011
  • 资助金额:
    $ 129.45万
  • 项目类别:
Identification of Pathways that Regulate Fibrosis through Collagen Resorption
鉴定通过胶原吸收调节纤维化的途径
  • 批准号:
    8092101
  • 财政年份:
    2011
  • 资助金额:
    $ 129.45万
  • 项目类别:
The Role of Collagen Uptake in Regulating the Severity of Pulmonary Fibrosis
胶原蛋白摄取在调节肺纤维化严重程度中的作用
  • 批准号:
    8207237
  • 财政年份:
    2011
  • 资助金额:
    $ 129.45万
  • 项目类别:
The Role of Collagen Uptake in Regulating the Severity of Pulmonary Fibrosis
胶原蛋白摄取在调节肺纤维化严重程度中的作用
  • 批准号:
    8050002
  • 财政年份:
    2011
  • 资助金额:
    $ 129.45万
  • 项目类别:
The Role of Collagen Uptake in Regulating the Severity of Pulmonary Fibrosis
胶原蛋白摄取在调节肺纤维化严重程度中的作用
  • 批准号:
    8402590
  • 财政年份:
    2011
  • 资助金额:
    $ 129.45万
  • 项目类别:
The Role of Mfge8 and Apoptotic Cell Clearance in Regulating Asthma Severity
Mfge8 和凋亡细胞清除在调节哮喘严重程度中的作用
  • 批准号:
    7638675
  • 财政年份:
    2009
  • 资助金额:
    $ 129.45万
  • 项目类别:

相似海外基金

Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10448926
  • 财政年份:
    2021
  • 资助金额:
    $ 129.45万
  • 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10491861
  • 财政年份:
    2021
  • 资助金额:
    $ 129.45万
  • 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10675535
  • 财政年份:
    2021
  • 资助金额:
    $ 129.45万
  • 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
  • 批准号:
    EP/S021868/1
  • 财政年份:
    2019
  • 资助金额:
    $ 129.45万
  • 项目类别:
    Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
  • 批准号:
    529840-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 129.45万
  • 项目类别:
    Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
  • 批准号:
    1403724
  • 财政年份:
    2014
  • 资助金额:
    $ 129.45万
  • 项目类别:
    Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
  • 批准号:
    1403697
  • 财政年份:
    2014
  • 资助金额:
    $ 129.45万
  • 项目类别:
    Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
  • 批准号:
    131690
  • 财政年份:
    2014
  • 资助金额:
    $ 129.45万
  • 项目类别:
    Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
  • 批准号:
    131338
  • 财政年份:
    2013
  • 资助金额:
    $ 129.45万
  • 项目类别:
    Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
  • 批准号:
    429734-2011
  • 财政年份:
    2012
  • 资助金额:
    $ 129.45万
  • 项目类别:
    Experience Awards (previously Industrial Undergraduate Student Research Awards)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了